5 chapters across the catalog
A significant deterrent for black gun ownership is the fear that police will mistake a legal gun owner for a criminal during a crisis. Mo'fax and Curry agree that a black man holding a gun at a crime scene is statistically more likely to be fired upon by arriving officers than a white man in the same position. They reiterate the need for Hollywood to change the cultural imagery of armed black men to mitigate this bias.
The hosts compare the media's treatment of the armed white protesters at the Bundy Ranch to the fatal shooting of Philando Castile, a legal black gun owner. While the Bundy group was often framed as "patriots" by some outlets, Castile was killed by an officer despite following legal protocols. Mo'fax highlights this as a clear example of the double standard facing black citizens who exercise their Second Amendment rights.
The NRA faced significant criticism for its silence following the acquittal of the officer who killed Philando Castile. Despite Castile being a lawful gun owner, the NRA declined to advocate for him, leading many to believe the organization prioritizes its relationship with law enforcement over the rights of black members. NAGA president Philip Smith notes that even a statement of disagreement would have been better than total silence.
Sean King claims to have raised over $34.5 million for various charities and social justice campaigns, backed by a seven-person expert review board. Families of high-profile victims, including the family of Botham Jean, have issued statements supporting King’s advocacy and personal involvement in their cases.
The discussion critiques conservative pundits like Larry Elders for using Black-on-Black crime as a deflection when discussing police shootings of Black men. The hosts highlight the case of Philando Castile, a legal gun owner killed by police, and the notable silence from the NRA on the matter. Additionally, the segment explores the lack of discussion regarding the mental health and medication use of police officers, suggesting Big Pharma's influence on media prevents such scrutiny.
